- Report
- September 2025
- 250 Pages
Global
From €4015EUR$4,490USD£3,483GBP
- Report
- October 2025
- 184 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- October 2025
- 195 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- October 2025
- 188 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- October 2025
- 194 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- October 2025
- 194 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- October 2025
- 180 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- October 2025
- 180 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- August 2025
- 181 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- August 2025
- 183 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- August 2025
- 194 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- August 2025
- 181 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- August 2025
- 196 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- August 2025
- 182 Pages
Global
From €3170EUR$3,545USD£2,750GBP
€3523EUR$3,939USD£3,055GBP
- Report
- September 2025
- 250 Pages
Global
From €4015EUR$4,490USD£3,483GBP
- Report
- September 2025
- 250 Pages
Global
From €4015EUR$4,490USD£3,483GBP
- Report
- March 2025
- 200 Pages
Global
From €2227EUR$2,490USD£1,931GBP
- Report
- October 2025
- 370 Pages
Global
From €5232EUR$5,850USD£4,538GBP
- Report
- October 2025
- 285 Pages
Global
From €5232EUR$5,850USD£4,538GBP
- Report
- October 2025
- 326 Pages
Global
From €5232EUR$5,850USD£4,538GBP

The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more